P1781
蝶酸
≥93%
别名:
4-[甲基[(2-氨基-4-羟基蝶啶)-6-基甲基]氨基]苯甲酸
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C14H12N6O3
化学文摘社编号:
分子量:
312.28
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
MDL number:
Assay:
≥93%
Form:
powder
InChI
1S/C14H12N6O3/c15-14-19-11-10(12(21)20-14)18-9(6-17-11)5-16-8-3-1-7(2-4-8)13(22)23/h1-4,6,16H,5H2,(H,22,23)(H3,15,17,19,20,21)
SMILES string
NC1=NC(=O)C2=NC(CNc3ccc(cc3)C(O)=O)=CNC2=N1
InChI key
JOAQINSXLLMRCV-UHFFFAOYSA-N
assay
≥93%
form
powder
Quality Level
Application
蝶酸可作为反应试剂：
- 与三氟乙酸酐经由酰化反应合成N-三氟乙酰蝶酸。
- 经由光断裂反应合成蝶酸的双癸基链衍生物。
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Sumith A Kularatne et al.
Methods in molecular biology (Clifton, N.J.), 624, 249-265 (2010-03-11)
Nanoparticulate medicines offer the advantage of allowing delivery of large quantities of unmodified drug within the same particle. Nanoparticle uptake by cancer cells can, however, be compromised due to the large size and hydrophilicity of the particle. To circumvent cell
Synthesis of pteroylglutamic acid (liver L. casei factor) and pteroic acid.
C W WALLER et al.
Journal of the American Chemical Society, 70(1), 19-22 (1948-01-01)
Synthesis of pteroylglutamic acid (liver L. casei factor) and pteroic acid.
M E HULTQUIST et al.
Journal of the American Chemical Society, 70(1), 23-23 (1948-01-01)
Preparation and purification of pteroic acid from pteroylglutamic acid (folic acid).
J M Scott
Methods in enzymology, 66, 657-660 (1980-01-01)
Berit Kühle et al.
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 194, 257-267 (2012-08-25)
The folate receptor (FR) is a very attractive target in oncological imaging as it is overexpressed by a variety of cancer types, whereas the expression in healthy tissue is very limited. The synthesis of regioisomeric pure folic acid derivatives normally
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持